Sachin S Shah
Overview
Explore the profile of Sachin S Shah including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
371
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shah S, Gvozdanovic A
Expert Rev Med Devices
. 2021 Nov;
18(sup1):5-8.
PMID: 34845960
No abstract available.
2.
Clift A, Le Lannou E, Tighe C, Shah S, Beatty M, Hyvarinen A, et al.
JMIR Mhealth Uhealth
. 2021 Feb;
9(2):e25655.
PMID: 33591285
Background: Given the established links between an individual's behaviors and lifestyle factors and potentially adverse health outcomes, univariate or simple multivariate health metrics and scores have been developed to quantify...
3.
Ohlsson A, Walia R, Shah S
Cochrane Database Syst Rev
. 2020 Feb;
2:CD003481.
PMID: 32045960
Background: Indomethacin is used as standard therapy to close a patent ductus arteriosus (PDA) but is associated with reduced blood flow to several organs. Ibuprofen, another cyclo-oxygenase inhibitor, may be...
4.
Ohlsson A, Shah S
Cochrane Database Syst Rev
. 2020 Jan;
1:CD004213.
PMID: 31985838
Background: Patent ductus arteriosus (PDA) complicates the clinical course of preterm infants and increases the risk of adverse outcomes. Indomethacin has been the standard treatment to close a PDA but...
5.
Ohlsson A, Shah S
Cochrane Database Syst Rev
. 2019 Jun;
6:CD004213.
PMID: 31222841
Background: Patent ductus arteriosus (PDA) complicates the clinical course of preterm infants and increases the risk of adverse outcomes. Indomethacin has been the standard treatment to close a PDA but...
6.
Ohlsson A, Walia R, Shah S
Cochrane Database Syst Rev
. 2018 Sep;
9:CD003481.
PMID: 30264852
Background: Indomethacin is used as standard therapy to close a patent ductus arteriosus (PDA) but is associated with reduced blood flow to several organs. Ibuprofen, another cyclo-oxygenase inhibitor, may be...
7.
Shah S, Ohlsson A, Halliday H, Shah V
Cochrane Database Syst Rev
. 2017 Oct;
10:CD002058.
PMID: 29041034
Background: Bronchopulmonary dysplasia (BPD) remains an important cause of mortality and morbidity in preterm infants and inflammation plays a significant role in its pathogenesis. The use of inhaled corticosteroids may...
8.
Shah S, Ohlsson A, Halliday H, Shah V
Cochrane Database Syst Rev
. 2017 Oct;
10:CD002057.
PMID: 29035425
Background: This is an update of a review published in 2012. A related review "Inhaled versus systemic corticosteroids for preventing bronchopulmonary dysplasia in ventilated very low birth weight preterm neonates"...
9.
Ohlsson A, Walia R, Shah S
Cochrane Database Syst Rev
. 2015 Feb;
(2):CD003481.
PMID: 25692606
Background: Indomethacin is used as standard therapy to close a patent ductus arteriosus (PDA) but is associated with reduced blood flow to several organs. Ibuprofen, another cyclo-oxygenase inhibitor, may be...
10.
Ohlsson A, Walia R, Shah S
Cochrane Database Syst Rev
. 2013 May;
(4):CD003481.
PMID: 23633310
Background: Indomethacin is used as standard therapy to close a patent ductus arteriosus (PDA) but is associated with reduced blood flow to several organs. Ibuprofen, another cyclo-oxygenase inhibitor, may be...